Skip to main content
. 2019 Jul 26;6(1):28–34. doi: 10.14338/IJPT-19-00067.1

Table 1.

Summary of demographics, treatment characteristics, and pelvic kidney dosimetry.

Patient
Age, y
Stage
Chemotherapy
Radiation dose, Gy
Radiation fraction
Kidney mean, Gy
Kidney V6, %
Kidney V20, %
1 63 IIIB T3N2M0 5-FU/mitomycin 54 30 3.6 18.26 5.79
2 62 II T2N0M0 5-FU/mitomycin 54 30 .95 4.16 0.02
3 60 IIB T3N0M0 5-FU/mitomycin 54 30 .58 2.47 0
4 60 II T3N0M0 None 50.4 28 .19 0.22 0

Abbreviation: 5-FU, 5-flourouracil.